STEVEN GILLIS

Profile

First Name

: STEVEN

Middle Name

:

Last Name

: GILLIS

Related Companies
Titles
Company Name
Related People
DIRECTOR
TRUBION PHARMACEUTICALS, INC
LEE R. BRETTMAN, MICHELLE BURRIS, KATHLEEN M. DEELEY, PATRICK HERON, ANDERS D. HOVE, DAVID A. MANN, KENDALL MOHLER, SAMUEL R. SAKS, DAVID SCHNELL, SCOTT STROMATT, PETER THOMPSON
DIRECTOR
PHASERX INC
BRIAN ATWOOD, BRIAN G. ATWOOD, RAYMOND CALVERT, JOHN DIEKMAN, JOHN D. DIEKMAN, MICHELLE GRIFFIN, MICHAEL HOUSTON, PAUL JOHNSON, PAUL H. JOHNSON, ANDREW LEON, ROBERT W. OVERELL, JOHN SCHMIDT, JOHN A. SCHMIDT, SHING-YIN (HELEN) TSUI, RICHARD ULEVITCH
DIRECTOR
PULMATRIX INC
ROBERT CLARKE, ROBERT CONNELLY, ROBERT T CONNELLY, ROBERT T. CONNELLY, DAVID EDWARDS, MARK GABRIELSON, KURT GRAVES, DAVID HAVA, MICHAEL HIGGINS, DAVID MAKI, TERRANCE MCGUIRE, TERRY MCGUIRE, SCOTT ROCKLAGE, LAUREN SILVERMAN
EXECUTIVE OFFICER, DIRECTOR
THERACLONE SCIENCES, INC.
WITOLD CIEPLAK, DAVID FANNING, WILLIAM GREENE, RUSS HAWKINSON, WENDE HUTTON, TERI KOLLER, CHRISTOPHER MIRABELLI, ELEANOR RAMOS, WENDYE ROBBINS, CLIFFORD STOCKS, KRISTINE SWIDEREK
DIRECTOR
MIRINA CORP
BRIAN ATWOOD, MERL F. HOEKSTRA, THONG LE, LINDSAY RAYLE, DAVID SCHUBERT, CHAD WAITE, CARL WEISSMAN
DIRECTOR
SURFACE LOGIX INC
KEITH DIONNE, WINSTON E. HENDERSON, DION MADSEN, W. JAMES O-SHEA, BRYAN ROBERTS, MARC RUBIN, IVO STAIJEN, PAUL SWEETNAM, GEORGE WHITESIDES
DIRECTOR
ACYLIN THERAPEUTICS, INC.
LEE BABISS, PETER DISTEFANO, STEVEN GILLS, THONG LE, JANIS NAEVE, LINDSAY RAYLE, CHAD WAITE, CARL WEISSMAN
DIRECTOR
BLUEBIRD BIO, INC.
JOHN AGWUNOBI, CHIP BAIRD, JASON COLE, WENDY DIXON, JAMES A. GERAGHTY, RAMY IBRAHIM, NICK LESCHLY, DANIEL S. LYNCH, JOHN M. MARAGANORE, GEERT-JAN MULDER, AXEL POLACK, WILLIAM R. SELLERS, ROBERT TEPPER, DENICE TORRES, MARK VACHON, JEFFREY T. WALSH
DIRECTOR
VARIATION BIOTECHNOLOGIES (US), INC.
DAVID E. ANDERSON, JEFF BAXTER, ADAM BUCKLEY, KEVIN FORREST, STEPHEN GILLIS, STEVE GILLIS, MARC J. KIRCHMEIER, JEFFREY LEIDEN, EGIDIO NASCIMENTO, SCOTT ROCKLAGE, MICHAEL STEINMETZ, STEVE VIGNAU, STEVEN VIGNAU
DIRECTOR
GROOVE BIOPHARMA CORP
BRIAN ATWOOD, MERL F. HOEKSTRA, THONG LE, LINDSAY RAYLE, DAVID SCHUBERT, CHAD WAITE, CARL WEISSMAN
DIRECTOR
ALLOZYNE INC
JOHN BENCICH, MEENU CHHABRA, KENNETH GRABSTEIN, MICHAEL STEINMETZ, DAVID TIRRELL, CARL WEISSMAN
DIRECTOR
PHASERX, INC.
BRIAN ATWOOD, BRIAN G. ATWOOD, RAYMOND CALVERT, JOHN DIEKMAN, JOHN D. DIEKMAN, MICHELLE GRIFFIN, MICHAEL HOUSTON, PAUL JOHNSON, PAUL H. JOHNSON, ANDREW LEON, ROBERT W. OVERELL, JOHN SCHMIDT, JOHN A. SCHMIDT, SHING-YIN (HELEN) TSUI, RICHARD ULEVITCH
DIRECTOR
VIRAL LOGIC SYSTEMS TECHNOLOGY CORP
BRIAN BLACKMAN, TERESA FOY, RON M. MYERS, GREGORY SESSLER, MARTIN A. SIMONETTI, DAVID URDAL, CARL WEISSMAN
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
FARADAY PHARMACEUTICALS, INC.
BRIAN BLACKMAN, LAWRENCE GOZLAN, PAULINA HILL, STEPHEN HILL, RONALD KIERPA, THOMAS KING, TERRANCE MCGUIRE, ROBERT NELSEN, PATRICK ROCK, MARK ROTH, SIMON TULLOCH
DIRECTOR
PULMATRIX OPERATING COMPANY, INC.
ROBERT CLARKE, ROBERT CONNELLY, ROBERT T CONNELLY, ROBERT T. CONNELLY, DAVID EDWARDS, MARK GABRIELSON, KURT GRAVES, DAVID HAVA, MICHAEL HIGGINS, DAVID MAKI, TERRANCE MCGUIRE, TERRY MCGUIRE, SCOTT ROCKLAGE, LAUREN SILVERMAN
DIRECTOR
LYCERA CORP
KRISTINA BUROW, KRISTINA BURROW, DAVID CANTER, STEVE GILLIS, GARY GLICK, GARY D. GLICK, MICHAEL HAYDEN, ROBERT KAMEN, NINA KJELLSON, JEFFREY LEIDEN, TIM MAYLEBEN, TIMOTHY MAYLEBEN, KATHLEEN M. METTERS, PAUL SEKHRI, MICHAEL STEINMETZ
DIRECTOR
PULMATRIX, INC.
AKIHISA AKAO, HOJABR ALIMI, RICHARD BATYCKY, TODD BAZEMORE, CHRISTOPHER CABELL, ROBERT CLARKE, RICHARD CONLEY, WILLIAM DUKE, GREGORY FRENCH, KURT GRAVES, SAMEER HARISH, DAVID HAVA, MICHAEL HIGGINS, MICHAEL J. HIGGINS, MARK IWICKI, PETER LUDLUM, DAVID MAKI, TERRANCE MCGUIRE, AMIT MUNSHI, AMIT D. MUNSHI, . OCULUS INNOVATIVE SCIENCES, INC., TEOFILO RAAD, JAMES ROACH, SCOTT ROCKLAGE, MATTHEW SHERMAN, MICHELLE S. SIEGERT, ANAND VARADAN
DIRECTOR
NEXGENIA INC.
RON MYERS, STEWART PARKER, MARTIN SIMONETTI, DAVID URDAL, CHARLES P. WAITE
DIRECTOR
CODIAK BIOSCIENCES, INC.
NOUBAR AFEYAN, CHARLES L COONEY, RAGHU KALLURI, ERIC LANDER, DOUG WILLIAMS
DIRECTOR
VBI VACCINES INC/BC
DAVID ANDERSON, DAVID E. ANDERSON, RON BARBARO, JEFF BAXTER, JEFFREY R. BAXTER, NELL BEATTIE, DAMIAN BRAGA, ANNIE CHAN, SAM CHAWLA, VIC CHEVILLON, VICTOR CHEVILLON, DOROTHY CHIN, JOANNE CORDEIRO, MICHEL DE WILDE, FRANCISCO DIAZ-MITOMA, CARLOS H. FERNANDEZ-MAZZI, STEVE GILLIS, WILLIAM C. GLASIER, TOMER KARIV, ATHENA KARTSAKLIS, CURT LOCKSHIN, ADAM LOGAL, JAMES MARTIN, AVI MAZALTOV, AVI E. MAZALTOV, BLAINE MCKEE, CHRISTOPHER MCNULTY, EGIDIO NASCIMENTO, SCOTT REQUADT, ROBERT ROBERTS, GARY ROBERTSON, STEVEN RUBIN, LISA SHARP, RON TREMBLAY, DAVID WOLFIN, LOUIS WOLFIN
DIRECTOR
NOHLA THERAPEUTICS INC.
BENJAMIN SCOT BERGO, IAN DAVID BROWN, GARY CHRISTIANSON, BRIAN DANIELS, COLLEEN DELANEY, KATHLEEN FANNING, LAWRENCE GOZLAN, JIM JOHNSON, DARREN SCOTTI, MICHAEL SISTENICH
DIRECTOR
HOMOLOGY MEDICINES, INC.
RICHARD GREGORY, KUSH PARMAR, SIYAMAK RASTY, ALBERT SEYMOUR, MAHENDRA SHAH, BRAD SMITH, PAUL STONE, ARTHUR TZIANABOS, CAMERON WHEELER
DIRECTOR
IMMUSANT, INC.
THOMAS DANIEL, CRAIG ESTWICK, KEVIN FERRO, CECLIA GONZALO, SUNDAR KODIYALAM, THOMAS KOESTLER, JUSTIN SUN, LESLIE WILLIAMS
DIRECTOR
ONCORESPONSE INC
ALICE BEXON, ROBERTO DE PONTI, ROBERTO DEPONTI, CAROL GALLAGHER, STEVE GILLIS, ALAN GINSBERG, RUSS HAWKINSON, PATRICK JOSEPH HOJLO, WENDE HUTTON, NATHAN JORGENSEN, TED KOUTOUZIS, BOB LECHLEIDER, ROBERT J. LECHLEIDER, SEAN MCCARTHY, SEAN A. MCCARTHY, JOHN MCKEARN, ANDREW PERLMAN, KAMAL PURI, KAMAL D. PURI, CHRIS RUSSELL, CHRISTOPHER A. RUSSELL, CLIFFORD STOCKS, CLIFFORD J. STOCKS, KRISTINE SWIDEREK, GEETA VEMURI, DAGUANG WANG
DIRECTOR
EGENESIS, INC.
JENNIFER BERGHEISER, GEORGE M. CHURCH, ISAAC CIECHANOVER, MICHAEL CURTIS, JUERGEN ECKHARDT, KENNETH FAN, KATHLEEN FANNING, STEPHEN GILLIS, PETER HANSON, LUCIO IANNONE, ARIEL JASIE, RAHUL KAKKAR, GEOFF MACKAY, BOB MORE, BORIS NIKOLIC, MARK PRUZANSKI, SARAH SCHLESINGER, PAUL SEKHRI, BRAD SMITH, SAPNA SRIVASTAVA, JULIE SUNDERLAND, ALBERT WIEGMAN, ALBERT L. WIEGMAN, LUHAN YANG
EXECUTIVE OFFICER
ARCH VENTURE FUND X, L.P.
N/A ARCH VENTURE PARTNERS X, L.P., N/A ARCH VENTURE PARTNERS X, LLC, KRISTINA BUROW, KEITH L. CRANDELL, MARK MCDONNELL, ROBERT T. NELSEN, PAUL THURK
EXECUTIVE OFFICER
ARCH VENTURE FUND X OVERAGE, L.P.
N/A ARCH VENTURE PARTNERS X OVERAGE, L.P., N/A ARCH VENTURE PARTNERS X, LLC, KRISTINA BUROW, KEITH L. CRANDELL, MARK MCDONNELL, ROBERT T. NELSEN, PAUL THURK
EXECUTIVE OFFICER
ARCH VENTURE FUND XI, L.P.
N/A ARCH VENTURE PARTNERS XI, L.P., N/A ARCH VENTURE PARTNERS XI, LLC, KRISTINA BUROW, KEITH L. CRANDELL, JASON DOREN, MARK MCDONNELL, ROBERT T. NELSEN
DIRECTOR
HC BIOSCIENCE, INC.
CHRISTOPHER AHERN, BENJAMIN CHEN, SACHA MANN, BRAD MARGUS, SEIJI MIYAHARA, DAVID MOSKOWITZ, LESLIE J WILLIAMS
EXECUTIVE OFFICER
ARCH VENTURE FUND XII, L.P.
N/A ARCH VENTURE PARTNERS XII, L.P., N/A ARCH VENTURE PARTNERS XII, LLC, PAUL BERNS, KRISTINA BUROW, KEITH L. CRANDELL, JASON DOREN, MARK MCDONNELL, ROBERT T. NELSEN
DIRECTOR
PHEAST THERAPEUTICS, INC.
AMIRA BARKAL, THOMAS MARTY, ROY MAUTE, RAPHAEL ROUSSEAU, JACOB VOGELSTEIN, IRVING WEISSMAN
DIRECTOR
SONOTHERA, INC.
MICHAEL DAVIDSON, RAKHSHITA DHAR, STEVEN FEINSTEIN, KENNETH GREENBERG, BRIAN HALAK, LORI HU, RAJUL JAIN, TOM WILLIS, ASISH XAVIER, CAROLYNE ZIMMERMAN
DIRECTOR
PRONIRAS CORP
M. JOHNSTON ERWIN, STEVE GILLIS, THONG LE, JOEL MARCUS, LINDSAY RAYLE, ATUL SARAN, DAVID SCHUBERT, CHRISTOPHER TOOMBS, ASISH XAVIER
DIRECTOR
ONCORESPONSE, INC
ALICE BEXON, ROBERTO DE PONTI, ROBERTO DEPONTI, CAROL GALLAGHER, STEVE GILLIS, ALAN GINSBERG, RUSS HAWKINSON, PATRICK JOSEPH HOJLO, WENDE HUTTON, NATHAN JORGENSEN, TED KOUTOUZIS, BOB LECHLEIDER, ROBERT J. LECHLEIDER, SEAN MCCARTHY, SEAN A. MCCARTHY, JOHN MCKEARN, ANDREW PERLMAN, KAMAL PURI, KAMAL D. PURI, CHRIS RUSSELL, CHRISTOPHER A. RUSSELL, CLIFFORD STOCKS, CLIFFORD J. STOCKS, KRISTINE SWIDEREK, GEETA VEMURI, DAGUANG WANG
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-06-30
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2026-06-08 
2025-10-16
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-10-07 
2025-05-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-04-21 
2025-04-10
D/A
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-01-31 
2025-01-29
D/A
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2023-12-15 
2024-02-27
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Debt 
2024-02-13 
2023-12-29
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2023-12-15 
2023-05-12
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-05-01 
2022-12-29
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-04-29 
2022-11-07
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-10-24 
2022-11-01
D/A
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2021-12-03 
2022-10-28
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-01-31 
2022-09-28
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-09-14 
2022-04-01
D/A
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2022-02-04 
2021-12-17
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2021-12-03 
2021-03-31
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-03-17 
2021-03-10
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-02-26 
2021-01-28
D/A
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2020-11-20 
2020-07-20
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2020-07-09 
2020-04-24
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2020-04-16 
2019-11-14
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-11-01 
2019-10-25
D/A
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2018-11-16 
2019-10-25
D/A
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2018-11-16 
2019-09-12
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2019-08-29 
2019-03-19
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2019-03-05 
2019-02-14
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2019-02-04 
2019-02-14
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2019-02-12 
2019-02-14
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2019-01-31 
2018-12-18
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2018-12-03 
2018-09-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-08-23 
2018-05-16
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-05-01 
2018-05-15
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2018-05-08 
2017-11-30
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-11-17 
2017-11-16
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-11-18 
2017-11-14
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-11-07 
2017-08-10
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2017-07-28 
2017-04-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2017-03-23 
2017-02-21
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2014-07-09 
2017-02-16
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-12-22 
2016-12-20
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2016-12-06 
2016-12-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-11-18 
2016-08-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-08-05 
2016-07-05
D
Link
BIOTECHNOLOGY 
GOLD + SILVER ORES [1040] 
DECLINE TO DISCLOSE 
Equity 
2016-06-20 
2016-06-09
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2016-06-07 
2015-12-29
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2015-12-21 
2015-11-25
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-11-12 
2015-06-30
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2015-06-15 
2015-06-30
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-06-15 
2015-06-30
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2015-06-15 
2015-06-30
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-03-13 
2015-06-30
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2015-06-15 
2015-06-30
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2015-06-15 
2015-06-29
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-06-17 
2015-06-22
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2015-06-12 
2015-05-07
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-04-24 
2014-07-23
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2014-07-09 
2013-12-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2013-12-04 
2013-10-02
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2013-09-19 
2013-08-16
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2013-03-22 
2013-07-29
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2013-03-11 
2013-07-29
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2013-03-11 
2013-07-11
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2013-06-28 
2013-04-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2013-03-22 
2013-03-26
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-03-11 
2013-02-22
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2011-08-02 
2012-12-21
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-12-10 
2012-10-26
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2011-08-02 
2012-08-31
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-08-17 
2012-07-25
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-07-23 
2012-07-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-07-02 
2012-06-29
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-06-20 
2012-06-14
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-06-11 
2012-06-01
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-05-25 
2012-05-18
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2012-05-10 
2012-02-14
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-02-01 
2012-02-03
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-01-25 
2011-12-20
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2011-12-07 
2011-11-23
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-08-30 
2011-09-12
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-08-30 
2011-08-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2011-08-02 
2011-07-15
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2011-06-03 
2011-07-15
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2010-11-17 
2011-04-27
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-03-05 
2011-04-27
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-04-15 
2010-12-01
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-11-18 
2010-12-01
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-11-17 
2010-07-16
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-07-02 
2010-04-28
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2010-04-16 
2010-03-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-03-17 
2010-02-22
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-08-17 
2009-11-02
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-10-16 
2009-09-04
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2009-09-01 
2009-08-26
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-08-17